Isis Pharmaceuticals CEO: Not changing name, terrorists can change theirs

Isis Pharmaceuticals chairman, president and CEO Dr. Stanley Crooke discusses the company's pipeline and deal with AstraZeneca. Dr. Crooke says the company is complicated story but its competitive advantage is incredible.